Genetic polymorphism intermingled with environmental factors substantially contributes to the bladder cancer progression.
作者信息
Wroński Stanisław
机构信息
Deptartment of Urology, Skin & Tissue Bank, Jan Biziel Memorial University Hospital, Bydgoszcz, Poland.
出版信息
Cent European J Urol. 2013;66(1):12-3. doi: 10.5173/ceju.2013.01.art4.
Abstract
摘要
相似文献
1
Genetic polymorphism intermingled with environmental factors substantially contributes to the bladder cancer progression.
Cent European J Urol. 2013;66(1):12-3. doi: 10.5173/ceju.2013.01.art4.
2
Functional RsaI/PstI polymorphism in cytochrome P450 2E1 contributes to bladder cancer susceptibility: evidence from a meta-analysis.
Asian Pac J Cancer Prev. 2014;15(12):4977-82. doi: 10.7314/apjcp.2014.15.12.4977.
3
Quantitative assessment of the association between glutathione S-transferase P1 Ile105Val polymorphism and bladder cancer risk.
Tumour Biol. 2013 Jun;34(3):1651-7. doi: 10.1007/s13277-013-0698-y. Epub 2013 Mar 13.
4
No association between HER-2 gene polymorphism at codon 655 and a risk of bladder cancer.
Int J Cancer. 2002 Feb 20;97(6):787-90. doi: 10.1002/ijc.10129.
5
Quantitative assessment of the association between TP53 Arg72Pro polymorphism and bladder cancer risk.
Mol Biol Rep. 2013 Mar;40(3):2389-95. doi: 10.1007/s11033-012-2319-z. Epub 2012 Nov 27.
6
p21 gene codon 31 polymorphism is associated with bladder cancer.
Urol Oncol. 2002 Mar-Apr;7(2):63-6. doi: 10.1016/s1078-1439(01)00152-1.
7
Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.
Cancer Epidemiol Biomarkers Prev. 2003 Nov;12(11 Pt 1):1234-40.
8
Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
Arch Toxicol. 2008 Sep;82(9):633-9. doi: 10.1007/s00204-007-0276-4. Epub 2008 Jan 16.
9
Nitric oxide synthase (eNOS4a/b) gene polymorphism is associated with tumor recurrence and progression in superficial bladder cancer cases.
J Urol. 2012 Dec;188(6):2398-403. doi: 10.1016/j.juro.2012.07.096. Epub 2012 Oct 22.
10
p53 codon 72 polymorphism as a progression index for bladder cancer.
Oncol Rep. 2012 Apr;27(4):1193-9. doi: 10.3892/or.2011.1610. Epub 2011 Dec 22.
引用本文的文献
1
Association between interleukin-22 genetic polymorphisms and bladder cancer risk.
Clinics (Sao Paulo). 2015 Oct;70(10):686-90. doi: 10.6061/clinics/2015(10)05.
本文引用的文献
1
Role of CYP1B1 gene polymorphisms in bladder cancer susceptibility.
J Urol. 2012 Feb;187(2):700-6. doi: 10.1016/j.juro.2011.10.063. Epub 2011 Dec 16.
2
Urinary human polyomavirus and papillomavirus infection and bladder cancer risk.
Br J Cancer. 2012 Jan 3;106(1):222-6. doi: 10.1038/bjc.2011.519. Epub 2011 Nov 24.
3
Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression.
Cancer Res. 2011 Dec 15;71(24):7376-86. doi: 10.1158/0008-5472.CAN-11-1154. Epub 2011 Oct 11.
4
Human papillomavirus infection and bladder cancer risk: a meta-analysis.
J Infect Dis. 2011 Jul 15;204(2):217-23. doi: 10.1093/infdis/jir248.
5
Genetic polymorphisms in CYP1A1, CYP1B1, COMT, GSTP1 and NAT2 genes and association with bladder cancer risk in a French cohort.
Anticancer Res. 2009 May;29(5):1631-5.
6
Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers.
Ann Oncol. 2007 Jul;18(7):1230-42. doi: 10.1093/annonc/mdm109. Epub 2007 May 11.
7
Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.
JAMA. 2006 Mar 22;295(12):1379-88. doi: 10.1001/jama.295.12.1379.
8
Polymorphisms of the CYP1B1 gene have higher risk for prostate cancer.
Biochem Biophys Res Commun. 2002 Aug 30;296(4):820-6. doi: 10.1016/s0006-291x(02)02004-1.
9
A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer.
Am J Hum Genet. 2002 Aug;71(2):432-8. doi: 10.1086/341943. Epub 2002 Jul 28.
Zotero 插件